{"id":5215,"date":"2016-01-29T18:16:00","date_gmt":"2016-01-29T20:16:00","guid":{"rendered":"https:\/\/www.biolabfarma.com.br\/?post_type=imprensa&#038;p=5215"},"modified":"2024-12-17T08:25:06","modified_gmt":"2024-12-17T11:25:06","slug":"cade-approves-pharmaceutical-joint-venture","status":"publish","type":"imprensa","link":"https:\/\/www.biolabeco.com.br\/en\/imprensa\/cade-aprova-joint-venture-farmaceutica\/","title":{"rendered":"Cade approves pharmaceutical joint venture"},"content":{"rendered":"<p>O Conselho Administrativo de Defesa Econ\u00f4mica (Cade) aprovou sem restri\u00e7\u00f5es joint venture entre Pfizer e Orygen Biotecnologia, controlada por Biolab e Eurofarma, conforme despacho publicado no Di\u00e1rio Oficial da Uni\u00e3o (DOU).<\/p>\n\n\n\n<p>A joint venture atuar\u00e1 na fabrica\u00e7\u00e3o e comercializa\u00e7\u00e3o no Brasil de at\u00e9 cinco biossimilares \u00e0 base de adalimumabe, bevacizumabe, infliximabe, rituximabe ou trastuzumabe. Segundo as empresas, a opera\u00e7\u00e3o representa a reformula\u00e7\u00e3o de acordo de coopera\u00e7\u00e3o firmado em maio de 2014, aprovado pelo Cade no mesmo ano. A Orygen Biotecnologia \u00e9 uma joint venture entre os grupos econ\u00f4micos Biolab e Eurofarma.<\/p>\n\n\n\n<p><a href=\"http:\/\/www.dci.com.br\/legislacao-e-tributos\/cade-aprova-joint-venture-farmaceutica-id524345.html\" target=\"_blank\" rel=\"noreferrer noopener\">Ver na \u00edntegra<\/a><\/p>","protected":false},"featured_media":0,"template":"","categories":[1577],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.4 (Yoast SEO v24.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cade aprova joint venture farmac\u00eautica - Biolab &amp; Co<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biolabeco.com.br\/en\/press\/cade-approves-pharmaceutical-joint-venture\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cade aprova joint venture farmac\u00eautica\" \/>\n<meta property=\"og:description\" content=\"O Conselho Administrativo de Defesa Econ\u00f4mica (Cade) aprovou sem restri\u00e7\u00f5es joint venture entre Pfizer e Orygen Biotecnologia, controlada por Biolab e Eurofarma, conforme despacho publicado no Di\u00e1rio Oficial da Uni\u00e3o (DOU). A joint venture atuar\u00e1 na fabrica\u00e7\u00e3o e comercializa\u00e7\u00e3o no Brasil de at\u00e9 cinco biossimilares \u00e0 base de adalimumabe, bevacizumabe, infliximabe, rituximabe ou trastuzumabe. Segundo [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biolabeco.com.br\/en\/press\/cade-approves-pharmaceutical-joint-venture\/\" \/>\n<meta property=\"og:site_name\" content=\"Biolab &amp; Co\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-17T11:25:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/\",\"url\":\"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/\",\"name\":\"Cade aprova joint venture farmac\u00eautica - Biolab &amp; Co\",\"isPartOf\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\"},\"datePublished\":\"2016-01-29T20:16:00+00:00\",\"dateModified\":\"2024-12-17T11:25:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biolabeco.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cade aprova joint venture farmac\u00eautica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\",\"url\":\"https:\/\/www.biolabeco.com.br\/\",\"name\":\"Biolab\",\"description\":\"Na Biolab &amp; Co, ci\u00eancia e cuidado caminham juntos. Saiba como promovemos sa\u00fade com responsabilidade socioambiental e tecnologia.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biolabeco.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cade approves pharmaceutical joint venture - Biolab &amp; Co","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biolabeco.com.br\/en\/press\/cade-approves-pharmaceutical-joint-venture\/","og_locale":"en_US","og_type":"article","og_title":"Cade aprova joint venture farmac\u00eautica","og_description":"O Conselho Administrativo de Defesa Econ\u00f4mica (Cade) aprovou sem restri\u00e7\u00f5es joint venture entre Pfizer e Orygen Biotecnologia, controlada por Biolab e Eurofarma, conforme despacho publicado no Di\u00e1rio Oficial da Uni\u00e3o (DOU). A joint venture atuar\u00e1 na fabrica\u00e7\u00e3o e comercializa\u00e7\u00e3o no Brasil de at\u00e9 cinco biossimilares \u00e0 base de adalimumabe, bevacizumabe, infliximabe, rituximabe ou trastuzumabe. Segundo [&hellip;]","og_url":"https:\/\/www.biolabeco.com.br\/en\/press\/cade-approves-pharmaceutical-joint-venture\/","og_site_name":"Biolab &amp; Co","article_modified_time":"2024-12-17T11:25:06+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/","url":"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/","name":"Cade approves pharmaceutical joint venture - Biolab &amp; Co","isPartOf":{"@id":"https:\/\/www.biolabeco.com.br\/#website"},"datePublished":"2016-01-29T20:16:00+00:00","dateModified":"2024-12-17T11:25:06+00:00","breadcrumb":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/cade-aprova-joint-venture-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biolabeco.com.br\/"},{"@type":"ListItem","position":2,"name":"Cade aprova joint venture farmac\u00eautica"}]},{"@type":"WebSite","@id":"https:\/\/www.biolabeco.com.br\/#website","url":"https:\/\/www.biolabeco.com.br\/","name":"Biolab","description":"At Biolab &amp; Co, science and care go hand in hand. Find out how we promote health with social and environmental responsibility and technology.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biolabeco.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/5215"}],"collection":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa"}],"about":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/types\/imprensa"}],"version-history":[{"count":1,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/5215\/revisions"}],"predecessor-version":[{"id":8368,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/5215\/revisions\/8368"}],"wp:attachment":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media?parent=5215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/categories?post=5215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}